Key Market Segments
By Type
-
Clinical Writing
-
Typewriting
-
Scientific Writing
-
Others
By End Use
-
Medical Devices
-
Pharmaceutical
-
Biotechnology
-
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
-
Mexico
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Turkey
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g., Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Ans: AI reduces documentation time by up to 40%, lowers human error, and enhances regulatory compliance, significantly improving both cost-efficiency and productivity for life sciences companies.
Ans: The market is expected to grow at a CAGR of 12.58% from 2025 to 2032, driven by rising demand for automation and regulatory compliance.
Ans: Investments are increasing in AI-driven content platforms, with companies like Biolevate, Indegene, and Aingens raising capital or launching AI tools to improve regulatory and clinical documentation efficiency.
Ans: Key players include Parexel International, Certara, IQVIA, ICON plc, Syneos Health, Freyr, Cactus Communications, GENINVO, IBM, and Teladoc Health.
Ans: The AI in medical writing market size was valued at USD 869.05 million in 2024 and is projected to reach USD 2240.06 million by 2032, growing at a CAGR of 12.58% from 2025 to 2032.